Ardelyx (ARDX) Receivables - Other (2018 - 2020)

Ardelyx's (ARDX) quarterly Receivables - Other came in at $750000.0 in Q3 2020, little changed on a QoQ basis from $750000.0 in Q2 2020.

Ardelyx (ARDX) Receivables - Other (2018 - 2020) Analysis & Trends

Ardelyx (ARDX) has 3 years of Receivables - Other data on file, last reported at $750000.0 in Q3 2020.

Quarterly Receivables - Other changed N/A year-over-year to $750000.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $750000.0 (changed N/A YoY) and the FY2019 annual result came in at $750000.0, down 85.0% from the prior year.
Receivables - Other steadied at $750000.0 in Q3 2020, from $750000.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $5.0 million in Q1 2018 to a low of $750000.0 in Q4 2019.
A 3-year average of $2.9 million and a median of $2.9 million in 2018 frame the typical range for Receivables - Other.
The widest YoY moves for Receivables - Other: up 85.0% in 2019, down 85.0% in 2019.
Tracing ARDX's Receivables - Other over 3 years: stood at $5.0 million in 2018, then plunged by 85.0% to $750000.0 in 2019, then changed by 0.0% to $750000.0 in 2020.
The last three Receivables - Other figures came in at $750000.0 (Q3 2020), $750000.0 (Q2 2020), and $750000.0 (Q1 2020), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Ardelyx	1.01 Bn	729.71 Mn	115.12 Mn

Download Data